Interestingly, we found inhibition of BAP1 dramatically destabilizes ASXL3 in SCLC cells and further disrupts the BAP1/ASXL3/BRD4 epigenetic axis. The gene discussed is ASXL3; the disease is small cell lung carcinoma.